Press statements

• Support for schools from NICE guidance

  16/06/2008

• NICE responds to Court of Appeal's ruling on Alzheimer's appraisal

  01/05/2008

• NICE welcomes new topic referral

  14/04/2008

• NICE welcomes new topic referral

  12/02/2008

• Adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis - appeal decision

  12/06/2007

• NICE respond to ´flawed and inaccurate´ drug industry sponsored report on cancer drugs

  21/05/2007

• NICE appraisal of bortezomib for the treatment of relapsed and refractory multiple myeloma

  20/10/2006

• NICE issues new draft guidance on primary and secondary prevention of osteoporosis

  03/10/2006

• Update on the development of the obesity guidance

  06/03/2006

• NICE draft report on Social Value Judgements

  28/11/2005

• NICE response to Audit Commission report - managing the financial implications of NICE Guidance

  08/09/2005

• NICE appraisal of capecitabine (Xeloda) for the treatment of colorectal cancer (adjuvant)

  12/08/2005

• NICE welcomes referral of trastuzumab (Herceptin) for treatment of early stage breast cancer

  21/07/2005

• Update on Alzheimer´s appraisal

  19/07/2005

• NICE consults on the factors it should consider when developing its guidance (for example age and lifestyle)

  06/05/2005

• Publication of NICE guidance

  12/04/2005

• NICE asked to develop first guidance on public health topics, alongside additional clinical guidelines and technology appraisals

  05/04/2005

• NICE appraisal of Alzheimer´s drugs

  15/03/2005

• NICE Sponsors HSJ Awards

  05/07/2004

• NICE will not issue guidance during May 2004

  21/05/2004

• Press statement: Review of NICE Technology Appraisal Guidance No.s 28, 45 and 55 - Topotecan, PLDH and paclitaxel for ovarian cancer

  20/11/2003

• Clinical guideline on dental recall

  06/04/2004